$79.7 Million is the total value of Invenire Partners, LP's 29 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TTI | Buy | Tetra Technologies Inc | $4,418,250,000 | +46.8% | 1,075,000 | +1.4% | 5.54% | +73.9% |
DHX | Buy | DHI Group Inc | $3,891,906,000 | +4.2% | 654,102 | +9.3% | 4.88% | +23.5% |
PAR | Buy | PAR Technology Corp | $3,633,383,000 | +18.6% | 90,069 | +55.1% | 4.56% | +40.5% |
MCS | Buy | Marcus Corp | $3,533,415,000 | +14.9% | 199,628 | +16.0% | 4.43% | +36.2% |
PRIM | Buy | Primoris Services Corp | $3,465,810,000 | +1.4% | 145,500 | +2.1% | 4.35% | +20.2% |
SHYF | Buy | Shyft Group Inc | $3,434,061,000 | -20.7% | 95,100 | +7.9% | 4.31% | -5.9% |
CMCO | Buy | Columbus McKinnon Corp | $3,332,512,000 | -3.4% | 78,597 | +5.4% | 4.18% | +14.5% |
CTLP | Buy | Cantaloupe Inc | $3,027,923,000 | +21.4% | 447,256 | +59.2% | 3.80% | +43.9% |
DNOW | Buy | NOW Inc | $2,970,930,000 | +32.1% | 269,350 | +2.3% | 3.73% | +56.6% |
INFU | Buy | InfuSystem Holdings Inc | $2,871,429,000 | -40.9% | 293,003 | +2.6% | 3.60% | -30.0% |
HROW | Buy | Harrow Health Inc | $2,734,765,000 | -3.4% | 400,992 | +22.4% | 3.43% | +14.6% |
DLA | Buy | Delta Apparel Inc | $2,713,243,000 | +15.4% | 91,079 | +15.2% | 3.40% | +36.8% |
APYX | Buy | Apyx Medical Corp | $2,683,823,000 | -39.8% | 410,999 | +18.1% | 3.37% | -28.7% |
CRY | New | Artivion Inc | $2,138,000,000 | – | 100,000 | +100.0% | 2.68% | – |
SNCR | Buy | Synchronoss Technologies Inc | $1,861,336,000 | -4.2% | 1,075,917 | +35.1% | 2.34% | +13.6% |
NDLS | Buy | Noodles & Co | $1,571,405,000 | -16.8% | 263,217 | +26.4% | 1.97% | -1.4% |
MX | New | MagnaChip Semiconductor Corp | $1,564,175,000 | – | 92,500 | +100.0% | 1.96% | – |
EVRI | New | Everi Holdings Inc | $1,312,500,000 | – | 62,500 | +100.0% | 1.65% | – |
LLNW | New | Limelight Networks Inc | $861,300,000 | – | 165,000 | +100.0% | 1.08% | – |
New | Arena Group Holdings Inc/The | $458,845,000 | – | 42,368 | +100.0% | 0.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DHI Group Inc | 4 | Q3 2022 | 7.9% |
Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
Harrow Health Inc | 4 | Q3 2022 | 8.4% |
TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
Clarus Corp | 4 | Q3 2022 | 5.9% |
Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
PAR Technology Corp | 4 | Q3 2022 | 4.9% |
Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2023-03-31 |
SC 13G | 2023-01-23 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
D/A | 2019-03-12 |
D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.